This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Cedars-Sinai Medical Center. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Sandra Orsulic
Introduction
Sandra Orsulic is a prominent inventor based in Los Angeles, CA. She has made significant strides in the field of gynecological cancer research. Her work focuses on developing molecular signatures that can aid in the diagnosis and treatment of ovarian cancer.
Latest Patents
Sandra Orsulic holds a patent for "Molecular signatures of ovarian cancer." This patent describes gene signatures that provide prognostic, diagnostic, treatment, and molecular subtype classifications of ovarian cancers. The generation of ovarian cancer disease signatures (OCDSs) accounts for the molecular heterogeneity present in gynecological cancers. Additionally, an ovarian cancer fixed signature (OCFS) is detailed, which relates to the core programming of disease development. The patent also discusses an ovarian cancer stem cell (OCSC) signature. The development of various disease signatures suggests personalized treatment strategies focused on molecular subtypes of gynecological cancers, including triage tests for patients.
Career Highlights
Sandra Orsulic is affiliated with Cedars-Sinai Medical Center, where she conducts her research. Her work has been instrumental in advancing the understanding of ovarian cancer and its molecular characteristics.
Collaborations
Sandra collaborates with notable colleagues, including Xiaojiang Cui and Mourad Tighiouart. Their combined expertise contributes to the innovative research being conducted at Cedars-Sinai Medical Center.
Conclusion
Sandra Orsulic's contributions to ovarian cancer research through her patent and collaborative efforts highlight her role as a leading inventor in the field. Her work paves the way for personalized treatment strategies that can significantly impact patient outcomes.